On September 7, 2016, OrthoSynetics, Inc. (“OrthoSynetics”), a leading nationwide provider of non-clinical administrative services to orthodontic and pediatric dental practices, completed a sale transaction. The terms of the transaction and the buyer remain confidential.
Duff & Phelps acted as the financial advisor to OrthoSynetics in connection with the sale transaction.
OrthoSynetics, Inc. is a leading nationwide provider of non-clinical outsourced administrative services to orthodontic and pediatric dental practices. OrthoSynetics’ outsourced services support virtually every aspect of a practice’s non-clinical operations, including revenue cycle management, collections, payables processing, financial reporting, marketing, procurement, practice development, real estate services, information technology and human resources and staffing. With nearly 30 years of operating history, OrthoSynetics has established itself as a trusted resource to some of the leading orthodontic and pediatric dentistry practices in the U.S. Waller Lansden Dortch & Davis LLP served as legal counsel to OrthoSynetics.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.Corporate Finance
Healthcare expertise for middle-market M&A transactions.Healthcare M&A
Transaction Advisory Services
Seamless analytical advisory through the deal continuum, from transaction origination to closing.Transaction Advisory Services
Fairness and Solvency Opinions
Independent opinions for boards of directors and special committees.Fairness and Solvency Opinions
has been acquired by
Duff & Phelps achieved a business turnaround following 18 months of trading, during which time the theme park and additional properties were developed through investment of £35m. Exit was via CVA which enabled dividend to be paid to unsecured creditors.
has received a USD 40,000,000 Loan Facility.
has received a dual tranche credit facility.
has received a credit facility to finance the acquisition of
a portfolio company of
Unitranche Credit Facility
has received an equity investment from
has sold substantially all of its assets to
March 21-23, 2018 Hollywood
March 20-21, 2018 London , UK